The FDA has cleared Perrigo's version of Klaron, Sanofi-Aventis' topical acne drug. The final approval allows Perrigo to launch its sulfacetamide sodium topical suspension.
Published in Brief:
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||